http://www.physorg.com/ en-us Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. A new study indicates dentists can play a potentially life-saving role in health care by identifying patients at risk of fatal heart attacks and referring them to physicians for further evaluation. http://www.physorg.com/news176649060.html Medicine & Health Thu, 05 Nov 2009 13:30:01 EST news176649060 Patient race, gender and insurance status influence decisions about who will go on to receive liver transplants, according to a University of Pittsburgh School of Medicine study. Available online and published in the September issue of the American Journal of Transplantation, the study indicates that women, blacks and patients with Medicare who are in end-stage liver disease are less likely to be referred and evaluated for liver transplantation. http://www.physorg.com/news170937598.html Medicine & Health Mon, 31 Aug 2009 11:40:26 EST news170937598 A blood-pressure medicine has been shown to reverse the effects of early-stage liver failure in some patients. http://www.physorg.com/news163061294.html Medicine & Health Mon, 01 Jun 2009 07:48:39 EST news163061294 Here's one more reason to keep your teeth healthy. http://www.physorg.com/news162744151.html Medicine & Health Thu, 28 May 2009 15:42:53 EST news162744151 Being overweight or obese is a leading contributor to cardiovascular disease (CVD) and associated risk factors; however, in patients with established CVD, obesity appears to play a protective role. In fact, data suggest obese patients with heart disease do better and tend to live longer than leaner patients with the same severity of disease, according to a review article published in the May 26, 2009, issue of the Journal of the American College of Cardiology. http://www.physorg.com/news161887269.html Medicine & Health Mon, 18 May 2009 17:41:32 EST news161887269 Peripheral arterial disease (PAD) of the legs, in which the arteries become blocked with plaque and blood supply to the legs is reduced, affects eight million people in the U.S. Early detection of PAD is important because it can limit the ability to walk and exercise, it may place patients at greater risk for limb loss and it increases the chance of having a heart attack or stroke. Coronary artery disease (CAD) is prevalent in patients with PAD and it is known that PAD is under diagnosed in the primary care setting, but a new study found that it is often overlooked even in patients with known heart disease who are under a cardiologist's care. The study was published in the May issue of Catheterization and Cardiovascular Interventions, the official journal of The Society for Cardiovascular Angiography and Interventions (SCAI). http://www.physorg.com/news160141605.html Medicine & Health Tue, 28 Apr 2009 12:47:45 EST news160141605 Scientists at Albert Einstein College of Medicine of Yeshiva University have previously shown that the co-mingling of three cell types can predict whether localized breast cancer will spread throughout the body. Now, a collaborative study led by investigators at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, has produced a test for metastasis that could help doctors precisely identify which patients should receive aggressive therapy. This might spare many women at low risk for metastatic disease from undergoing unnecessary and potentially dangerous treatment. The findings were published today in the online version of Clinical Cancer Research. http://www.physorg.com/news157123728.html Medicine & Health Tue, 24 Mar 2009 14:30:09 EST news157123728 Liver cancer in patients whose only risk factor is metabolic syndrome has distinct forms and structures compared to other liver tumors. These findings are in the March issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver Diseases (AASLD). http://www.physorg.com/news154789424.html Medicine & Health Wed, 25 Feb 2009 13:04:46 EST news154789424 There is hope that the drug rasagiline can do what no other medication for Parkinson's disease now does -- slow the progression of a devastating degenerative brain disease that eventually robs people of their ability to move and function. http://www.physorg.com/news152193298.html Medicine & Health Mon, 26 Jan 2009 11:56:51 EST news152193298 Bladder cancer is much more likely to be deadly for women and African-Americans, but the reasons long believed to explain the phenomenon account for only part of the differences for such patients compared to their white and male counterparts, according to results published in the Jan. 1 issue of the journal Cancer. http://www.physorg.com/news150646734.html Medicine & Health Thu, 08 Jan 2009 14:18:54 EST news150646734 Implantable cardioverter defibrillators (ICDs) can improve survival in patients with heart damage - even those in their 70s - according to research reported in Circulation: Cardiovascular Quality and Outcomes. http://www.physorg.com/news150482825.html Medicine & Health Tue, 06 Jan 2009 16:47:05 EST news150482825 According to the latest study by Dr. Ronald Postuma from the Research Institute of the MUHC and Dr. Jacques Montplaisir from the Université de Montréal and the Hôpital du Sacré-Cœur de Montréal, 52.4 per cent of patients with REM sleep behaviour disorder develop a neurodegenerative disease within 12 years following their initial diagnosis. These results will be published on December 24, 2008 in the journal Neurology, the official publication of the American Academy of Neurology. http://www.physorg.com/news149362978.html Medicine & Health Wed, 24 Dec 2008 17:42:58 EST news149362978 Parkinson`s disease affects 6.3 million people worldwide. While the disease is recognized for its profound effects on movement, up to 40 percent of Parkinson`s disease patients also develop changes in thought, behavior and judgment. http://www.physorg.com/news148315047.html Medicine & Health Fri, 12 Dec 2008 14:37:27 EST news148315047 Treating patients who have chronic hepatitis C and advanced liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and liver inflammation, but the treatment did not slow or prevent the progression of serious liver disease, a study finds. http://www.physorg.com/news148053947.html Medicine & Health Tue, 09 Dec 2008 14:05:47 EST news148053947 An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment. In addition, the study showed a surprising health decline in patients with liver disease over the course of four years. http://www.physorg.com/news147551365.html Medicine & Health Wed, 03 Dec 2008 18:29:25 EST news147551365 Cardiac CT can effectively assess coronary artery stenosis, according to a large study performed at Leiden University Medical Center in Leiden, The Netherlands. http://www.physorg.com/news147358007.html Medicine & Health Mon, 01 Dec 2008 12:46:47 EST news147358007 Acute kidney injury (AKI) -which is often caused by trauma, illness, or surgery -predisposes elderly individuals to the most serious form of chronic kidney disease (CKD), known as end stage renal disease (ESRD), according to a study appearing in the January 2009 issue of the Journal of the American Society Nephrology (JASN). The findings indicate that close medical follow-up is important for maintaining the health of patients who have experienced kidney damage. http://www.physorg.com/news146335207.html Medicine & Health Wed, 19 Nov 2008 16:40:07 EST news146335207 A study in the Sept. 21 on-line edition of Nature Medicine describes the function and interaction of a critical molecule involved in cell death in Alzheimer's disease patients. These new findings reveal that blocking this molecule, called Cyclophilin D (CypD), and development of surrounding mitochondrial targets may be viable therapeutic strategies for the prevention and treatment of Alzheimer's disease, according to Shi Du Yan, Ph.D., professor of clinical pathology in the Department's of Pathology and Surgery and in the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center, who led the multi-center research. http://www.physorg.com/news145124623.html Medicine & Health Wed, 05 Nov 2008 16:23:43 EST news145124623 New research may help reveal why different parts of the brain can come under attack in patients with multiple sclerosis (MS). According to a new study in mice with an MS-like disease, the brain's response to a protein produced by invading T cells dictates whether it's the spinal cord or cerebellum that comes under fire. The study -from researchers at the University of Maryland School of Medicine in Baltimore and Washington University in St. Louis -will be published online on October 13th in the Journal of Experimental Medicine. http://www.physorg.com/news143106815.html Medicine & Health Mon, 13 Oct 2008 08:53:35 EST news143106815 The U.S. Food and Drug Administration today approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease. http://www.physorg.com/news138071747.html Medicine & Health Sat, 16 Aug 2008 02:15:47 EST news138071747 Distinct genetic profiles can discern different groups of patients with scleroderma, a vexing autoimmune disease in which the body turns against itself, Dartmouth Medical School researchers report. Their discovery of distinguishing molecular subtypes within the disease offers new insight into the complexity of a poorly understood and hard to treat illness and opens a window for better diagnosis and targeted therapies. http://www.physorg.com/news135404369.html Medicine & Health Wed, 16 Jul 2008 05:19:29 EST news135404369